CA
NZ
UK
AU
IND
US
SpyGlass Pharma, Inc. filed a Form 8-K on November 12, 2026, reporting its third-quarter 2026 financial results and disclosing that it completed its first implantations in a first-in-human study of its Bimatoprost-Drug Ring System in October 2026.
Alliance Entertainment Holding Corporation filed a Form 8-K with the SEC on November 12, 2026, announcing the issuance of a press release covering financial results for the fiscal quarter ended September 30, 2026, and the release of an updated investor presentation.
Clarivate Plc (NYSE:CLVT) announced on November 12, 2026, the expiration and final results of cash tender offers by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, to purchase its 3.875% Senior Secured Notes due 2028 and 4.875% Senior Notes due 2029, with $533,000,000 total aggregate …
enCore Energy Corp. filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, reporting third-quarter revenue of $16.7 million alongside a net loss attributable to enCore of $33.9 million, with the filing made on November 12, 2026.
Clarivate Science Holdings Corporation announced on November 12, 2026 the expiration and final results of its cash tender offers for two series of outstanding senior notes, with a total of $533,000,000 aggregate principal amount accepted for purchase following a 2% upsize exercise.
NextPlat Corp (NASDAQ:NXPL) released its third-quarter operating results for the period ended September 30, 2026, disclosing significant margin improvement alongside a contraction in total consolidated revenue compared with the year-earlier period.
Suburban Propane Partners, L.P. filed an earnings announcement on November 12, 2026, reporting full-year and fiscal fourth-quarter results for the period ended September 26, 2026.
HawkEye 360, Inc. filed an 8-K on November 12, 2026, announcing approximately $135 million in new global contracts signed since October 1, 2026, including more than $70 million in European awards.
Farallon Capital Management, L.L.C. and associated individuals filed an amended beneficial ownership statement with the SEC on November 12, 2026, reporting shared ownership of 14,247,000 shares of BridgeBio Pharma, Inc. common stock as of September 30, 2026.
TE Connectivity plc filed an 8-K on November 12, 2026, disclosing a planned investment of more than $60 million in an advanced research, development, and manufacturing facility in Henrietta, New York, focused on fiber optic solutions for AI data centers and cloud providers.
Please wait processing your request...